Pharmocann Global Ltd. Logo

Pharmocann Global Ltd.

Develops pharma-grade medical cannabis products like oils, ointments, tablets, and cosmetics.

PMCN-M | TA

Overview

Corporate Details

ISIN(s):
IL0010968902
LEI:
Country:
Israel
Address:
Horesh Haalonim 1, 3009500 Ramat Yishai
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Blue Wave Water Capital Ltd., formerly known as Pharmocann Global Ltd., is a publicly traded company with over 14 years of experience in the medical cannabis industry. The company has historically specialized in the development and production of pharma-grade medical cannabis products, including oils, ointments, tablets, and inhalers, as well as hemp-based cosmetics and seed oils. A recent corporate decision resulted in a name change and a strategic shift, with the company now operating as Blue Wave Water Capital Ltd.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-04 19:38
Regulatory News Service
The sector classification of BLUE WAVE WATER CAPITAL will be changed, as of Au…
English 99.3 KB
2025-02-17 18:43
Regulatory News Service
Changes in the company's name and security, effective as of February 19, 2025
Hebrew (modern) 118.3 KB
2023-10-03 16:36
Regulatory News Service
Excellence will cease to operate as a market maker in the company's shares as o…
Hebrew (modern) 118.8 KB
2020-08-23 11:39
Investor Presentation
Investors Presentation - August 2020
English 20.2 MB
2020-08-23 11:39
Registration Form
Investors Presentation - August 2020
Russian 42.3 KB

Automate Your Workflow. Get a real-time feed of all Pharmocann Global Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Pharmocann Global Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.